Work

Phase I/II Study of Oral FodosineTM, a PNP Inhibitor in Refractory Cutaneous T-Cell Lymphoma Patients.

Year: 2005

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v106.11.2683.2683

Authors: Madeleine Duvic, Debra Breneman, Maureen Cooper, Gustavo Fonseca, J. Claude Bennett, J. Michael Kilpatrick, Shanta Bantia

Institutions: The University of Texas MD Anderson Cancer Center, University of Cincinnati, BioCryst Pharmaceuticals (United States)

Language: English

Topic: Cutaneous lymphoproliferative disorders research

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2557560675

FWCI: 0.842

Cites:

Cited by: 2

Related to: 10